The first report of the latin American society of nephrology and hypertension (SLANH) anemia committee in chronic hemodialysis patients

Nefrologia

Volumn 34, Issue 1, 2014, Pages 96-104

  Carlini, Raúl ^a   Obrador, Gregorio ^b   Campistrús, Nieves ^c   Andrade, Liliana ^d   Chifflet, Liliana ^e   Bregman, Rachel ^f   Locatelli, Alberto ^g   Correa Rotter, Ricardo ^h   Poblete, Hugo ⁱ  

^a HOSPITAL UNIVERSITARIO DE CARACAS   (Venezuela)

^b UNIVERSIDAD PANAMERICANA   (Mexico)

^c Uruguayana   (Uruguay)

^d Churruca Visca Hospital   (Argentina)

^e Division of Dialysis   (Uruguay)

^f STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^g Nefronosa Service SA   (Argentina)

^h Salvador Zubirán ^*  (Mexico)

ⁱ Dialysis Center Sermedial   (Chile)

Author keywords

Anemia; Hemodialysis; Latin america; Survey

Indexed keywords

ANEMIA; COMPLICATION; CROSS-SECTIONAL STUDY; FEMALE; HEALTH CARE SURVEY; HUMAN; KIDNEY FAILURE, CHRONIC; MALE; MEDICAL SOCIETY; MIDDLE AGED; NEPHROLOGY; RENAL REPLACEMENT THERAPY; SOUTH AND CENTRAL AMERICA;

ANEMIA; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH CARE SURVEYS; HUMANS; KIDNEY FAILURE, CHRONIC; LATIN AMERICA; MALE; MIDDLE AGED; NEPHROLOGY; RENAL DIALYSIS; SOCIETIES, MEDICAL;

EID: 84894302530     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: 10.3265/Nefrologia.pre2013.Oct.12234     Document Type: Article

References (20)

1. Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, Wolfson M, et al. for the CHOIR Investigators. Correction of Anemia with Epoetin Alfa in Chronic Kidney Disease. N Engl J Med 2006;355:2085-98.
2. Drüeke TB, Locatelli F, Clyne N, Eckardt K-U, Macdougall IC, Tsakiris D, et al. for the CREATE Investigators. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 2006;355:2071-84.
3. Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU et al.; TREAT Investigators. A trial of darbepoetinalfa in type 2 diabetes and chronic kidney disease. N Engl J Med 2009;361(21):2019-32.
4. Coyne DW. The health-related quality of life was not improved by targeting higher hemoglobin in the Normal Hematocrit Trial. Kidney Int 2012;82:235-41.
5. KDOQI clinical practice guideline and clinical practice recommendations for anemia in chronic kidney disease, 2007 update of hemoglobin target. Am J Kidney Dis 2007;50(3):471-530.
6. Locatelli F, Covic A, Eckardt K-U, Wiecek A, Vanholder R, on behalf of the ERA-EDTA ERBP Advisory Board. Anaemia management in patients with chronic kidney disease: a position statement by the Anaemia Working Group of European Renal Best Practice (ERBP). Nephrol Dial Transplant 2009;24:348-54.
7. Carlini R, Campistrús N, Andrade L, Bregman R, Chifflet L, Correa-Rotter R, et al. Recommendations for the clinical practice of the Latino American Society of Nephrology and Hypertension (SLANH) for the treatment of anemia in patients with chronic renal disease (RPCA-ERC/SLANH). Nefrología Latinoamericana 2009;13:1-30.
8. KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease. Kidney Int Suppl 2012;(2):S299-310.
9. Cusumano AM, Gonzalez Bedat MC, García-García G, Maury Fernandez S, Lugon JR, Poblete BH, et al. Latin American Dialysis and Renal Transplant Registry: 2008 Report (data 2006). Clin Nephrol 2010;74 Suppl 1:S3-8.
10. Sesso R, Lopes AA, Thomé FS, Bevilacqua JL, Romão JE Junior, Lugon J. Brazilian Dialysis Census Report 2008. J Bras Nefrol 2008;30(4):233-8.
11. Gurgel TC, Cherchiglia ML, Acurcio F de A, Szuster DA, Campos DA, Gomes IC, et al. Erythropoietin use by incident HD patients in the Brazilian Unified National Health System, 2002-2003. Cad Saude Publica 2012;28(5):856-68.
12. González C, Ferreiro A, Schwedt E, Pinato M. 2009 Uruguayan Register Dialysis. Available at: http://www.nefrouruguay.com/
13. Poblete H. Chilenan Nephrology Society. Dialysis Register 2010. Available at: http://www.nefro.cl/registros/registro-de-hemodialisis. html
14. Tsubakihara Y, Nishi S, Akiba T, Hirakata H, Iseki K, Kubota M, et al. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease. Ther Apher Dial 2010;14(3):240-75.
15. National Institute for Health and Clinical Excellence (NICE). Anaemia management in people with chronic kidney disease. (CG114). 2011. Available at: http://guidance.nice.org.uk/CG114
16. Gilg J, Webb L, Feest T, Fogarty D. UK Renal Registry 13th Annual Report (December 2010): Chapter 9, haemoglobin, ferritin and erythropoietin amongst UK adult dialysis patients in 2009: national and center-specific analyses. Nephron Clin Pract 2011;119 Suppl 2:c149-77.
17. US Renal Data System, USRDS 2012 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2012. Available at: http://www.usrds.org/atlas.aspxcion
18. Hasegawa T, Bragg-Gresham JL, Pisoni RL, Robinson BM, Fukuhara S, Akiba T, et al. Changes in anemia management and hemoglobin levels following revision of a bundling policy to incorporate recombinant human erythropoietin. Kidney Int 2011;79(3):340-6.
19. Bamgbola OF. Pattern of resistance to erythropoietin stimulating agents in chronic kidney disease. Kidney Int 2011;80(5):464-74.
20. Elliot J, Mishler D, Agarwal R. Hyporesponsiveness to erythropoietin: causes and management. Adv Chronic Kidney Dis 2009;16(2):94-100.